Influence of clinically significant portal hypertension on hepatectomy for hepatocellular carcinoma: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1649-1654

  Tang, Yun Hao ^a   Zhu, Wen Jiang ^a   Wen, Tian Fu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Meta analysis; Portal hypertension

Indexed keywords

ARTICLE; ESOPHAGUS VARICES; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; META ANALYSIS; MORTALITY; PATHOLOGY; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; ESOPHAGEAL AND GASTRIC VARICES; HEPATECTOMY; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER NEOPLASMS; POSTOPERATIVE COMPLICATIONS; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84897016425     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1649     Document Type: Article

References (28)

1. Boleslawski E, Petrovai G, Truant S, et al (2012). Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis. Br J Surg, 99, 855-63.
2. Bruix J, Castells A, Bosch J, et al (1996). Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology, 111, 1018-22.
3. Bruix J, Sherman M (2005). Management of hepatocellular carcinoma. Hepatology, 42, 1208-36.
4. Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol, 35, 421-30.
5. Capussotti L, Ferrero A, Viganò L, et al (2006). Portal hypertension: contraindication to liver surgery? World J Surg, 30, 992-9.
6. Chen X, Zhai J, Cai X, et al (2012). Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg, 99, 1701-10.
7. Choi GH, Park JY, Hwang HK, et al (2011). Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int, 31, 485-93.
8. Cucchetti A, Ercolani G, Vivarelli M, et al (2009). Is portal hypertension a contraindication to hepatic resection? Ann Surg, 250, 922-8.
9. Giannini EG, Savarino V, Farinati F, et al (2013). Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int, 33, 1594-600.
10. Hidaka M, Takatsuki M, Soyama A, et al (2012). Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma. Br J Surg, 99, 1284-9.
11. Imamura H, Seyama Y, Kokudo N, et al (2003). One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg, 138, 1198-206.
12. Ishizawa T, Hasegawa K, Aoki T, et al (2008). Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology, 134, 1908-16.
13. Kawano Y, Sasaki A, Kai S, et al (2008). Short-and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol, 15, 1670-6.
14. Li SH, Guo ZX, Xiao CZ, et al (2013). Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection. Asian Pac J Cancer Prev, 14, 4759-63.
15. Llovet JM, Fuster J, Bruix J (1999). Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology, 30, 1434-40.
16. Parkin DM (2006). The global health burden of infection-associated cancers in the year 2002. Int J Cancer, 118, 3030-44.
17. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
18. Ruzzenente A, Valdegamberi A, Campagnaro T, et al (2011). Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated?. World J Gastroenterol, 17, 5083-8.
19. Santambrogio R, Kluger MD, Costa M, et al (2013). Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?. HPB, 15, 78-84.
20. Schindl MJ, Redhead DN, Fearon KC, et al (2005). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut, 54, 289-96.
21. Stremitzer S, Tamandl D, Kaczirek K, et al (2011). Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma. Br J Surg, 98, 1752-8.
22. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12.
23. van den Broek MA, Olde Damink SW, Dejong CH, et al (2008). Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int, 28, 767-80.
24. Vizzutti F, Arena U, Romanelli RG, et al (2007). Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology, 45, 1290-7.
25. Wong JS, Wong GL, Chan AW, et al (2013). Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes. Ann Surg, 257, 922-8.
26. Yang Ping-hua, Qu Shu-ping, Cheng Zhang-jun, et al (2012). Hepatic resection for hepatocellular carcinoma with portal hypertension. Chinese Hepatology, 17, 626-9.
27. Zhu W J, Huang C Y, Li C, et al (2013). Risk factors for early recurrence of hbv-related hepatocellular carcinoma meeting milan criteria after curative resection. Asian Pac J Cancer Prev, 14, 7101-6.
28. Ziol M, Handra-Luca A, Kettaneh A, et al (2005). Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology, 41, 48-54.